Leading expert headlines Research Day

Dr. Terry Kenakin, professor, Department Pharmacology, University of North Carolina School of Medicine will be the keynote speaker at the 2013 London Health Research Day on March 19. Considered a true powerhouse in receptor pharmacology, Dr. Kenakin will provide an interesting presentation of special interest to all.

Dr. Kenakin graduated with a BSc in Chemistry and then enrolled in the PhD Program in the Department of Pharmacology, University of Alberta in 1971 where he worked with Dr. David Cook. They studied histamine receptor pharmacology and Dr. Kenakin's first paper was published in Nature in Kenakin TP, Krueger CA, Cook DA. 1974 Temperature‐dependent interconversion of histamine H1 and H2 receptors in guinea pig ileum, Nature 252:54‐55.

Dr. Kenakin earned his PhD in Pharmacology in 1975 and started a highly successful Postdoctoral Fellowship under the expert tutelage of the 1988 Nobel Laureate Sir James Black at University College in London, England.

He then joined Burroughs‐Wellcome as an Associate Scientist. From there, he continued working in drug discovery at Glaxo Inc. and at GlaxoWellcome. Currently he is a Director at GlaxoSmithKline Research and Development Laboratories at Research Triangle Park, N.C. USA.

Dr. Kenakin has made many important contributions to pharmacology, having been involved in drug discovery for more than 35 years. Currently he is engaged in studies aimed at the optimal design of experimental systems for the assay of drug activities as well as the discovery and testing of allosteric molecules for the treatment of diabetes. He is a member of numerous editorial boards as well as Co-editor-in-Chief for the Journal of Receptors and Signal Transduction. Dr. Kenakin has authored numerous high impact journal articles and has written eight textbooks on receptor pharmacology, pharmacodynamics and drug discovery.